System will bring together stakeholders like manufacturers, distributors, state-run agencies to ensure quality
Proposals to be discussed at Hyderabad conclave include having a centralised drug registration system under CDSCO
Appointment comes at a time when India's pharma regulatory landscape is under the scanner
Firm under US FDA scanner for bacterial contamination of its eye drops
Business Standard brings you the top headlines at this hour
Global Pharma has initiated a voluntary recall at the consumer level of all unexpired lots of EzriCare Artificial Tears and Delsam Pharma's Artificial Tears
The US FDA said that using contaminated artificial tears increases risk of eye infections that could result in blindness or death
Cough syrup maker linked to Uzbekistan deaths halts production; samples of Dok-1 Max sent for analysis
Objective of drug regulation is to ensure safety, efficacy, and quality of drugs
The Central Drugs Standard Control Organisation (CDSCO) approved the recombinant nasal COVID-19 vaccine on September 5 this year for those aged 18 years and above, Minister of State for Health Bharati Pravin Pawar told the Rajya Sabha on Tuesday. In a written reply, Pawar said the vaccine is to be given in two doses of 0.5 ml each in a gap of 28 days. It is to be administered intranasally. Under the Vaccine Maitri Programme, India has supplied COVID-19 vaccine to more than 90 countries in the form of grant, commercial export or through the global vaccine alliance COVAX, Pawar said.
Indian Health ministry sources say the Haryana-based drug maker is currently being probed for lapses in good manufacturing practices
According to the media reports, Karnataka has directed all drugmakers to test samples of glycerine and propylene glycol and submit a report within seven days.
Centre forms panel to analyse causal relation between deaths and cough syrups
The firm has been in news for supplying contaminated cough syrups to Gambia, which is linked to the deaths of 66 children due to the presence of contaminants
After the World Health Organization issued an alert on four India-made cough and cold syrups used for paediatric groups, the Central Drugs Standard Control Organisation has taken up an urgent probe
CDSCO aims to phase out these combinations and codeine-based drugs in a phased manner
The report presented in the Parliament by a standing committee stated that along with more testing labs, the country needs a robust IT-enabled and feedback-driven post-sales surveillance system
Guljit Sethi of Bioinnovat was named in CBI FIR on a bribery case involving CDSCO official and Biocon Biologics executive
Gemcovac does not require sub-zero temperatures for storage and transport, unlike two other international doses
All five apprehended will be presented in court on Tuesday afternoon, agency to seek police custody